Category Archives: Cardiovascular

Edwards gains CE mark approval for new tricuspid valve replacement device

Edwards has been evaluating the safety and effectiveness of the Evoque system for quite some time. In November 2022, the company shared one-year data from the TRISCEND study that linked the system to a survival rate of 90.1% and sustained TR reduction in 97.6% of patients. Now, the company is preparing to share findings from […]

How Cutting Corners on Dental Hygiene Can Mess With Your Heart

Another problem with dirty teeth, according to Dr. Jeong? Inflammation. It can be triggered throughout your body—not just in your mouth—by oral conditions like gum disease or cavities. For example, when you have gum disease, your body produces inflammatory chemicals, which, like the bacteria, can circulate throughout your system, Dr. Rosen says. Why does this […]

A Link Between Genetic Damage and Cardiovascular Disease

To do this, we need your support. Your charitable contribution tranforms into rejuvenation research, news, shows, and more. Will you help? .rb-124013-4e8f79653240e1 a{background-color:#bf5615}.rb-124013-4e8f79653240e1 a:hover{background-color:#1f7d22} In a paper published in Aging, researchers have explored the relationship between DNA damage and aging of the blood vessels. How arteries age This paper begins with some well-known facts about […]

Dr. Crawford on cardiovascular risk with ADT in prostate cancer

In this video, E. David Crawford, MD, highlights the background and findings from the study, “Cardiovascular risk in prostate cancer patients using luteinizing hormone-releasing hormone agonists or a gonadotropin-releasing hormone agonist,” for which he served as the lead author. Crawford is a professor of urology at the University of California, San Diego. Video Transcript: For […]

Walgreens Collaborates with Cardiovascular Research Foundation on Valvular Heart Disease Clinical Trial

Credit: wildpixel / iStock Walgreens and the Cardiovascular Research Foundation (CRF) announced a collaboration on a population-based clinical trial that seeks to quantify the prevalence of valvular heart disease (VHD) in older Americans. Under the terms of the deal, Walgreens will leverage its broad national presence to help recruit potential trial participants employing its clinical […]

Philips showcases latest medical innovations and solutions for patients with cardiovascular disease at the TCT international meeting

Over the coming days, Philips will be presenting its latest solutions in cardiology and new late-breaking clinical data at the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting (October 23-26 in San Francisco, USA). Philips will feature a comprehensive portfolio of image-guided therapy and echocardiography solutions that integrate advanced imaging systems and software with specialized diagnostic and […]

Heart diseases among top killers

KARACHI: Cardiovascular diseases (CVDs) are the leading cause of death worldwide. During Covid-19 from 2019 to 2022 around three million people died but as per estimates shared by the World Health Organization the CVDs killed around 20.6 million people every year across the globe said Consultant Cardiologist, National Medical Centre, United Hospital Karachi, Dr Rehan […]

Lankenau renames cardiovascular imaging center after generous donors

Lankenau Medical Center, 100 E Lancaster Ave, Wynnewood, recently renamed and rededicated the cardiovascular imaging center after a generous donation. The center is now called the Penny and Warren Heart Pavilion. The gift will fund a modern imaging suite in the building and other enhancements, Lankenau said. Fall-prevention classes offered The Delaware County County Office […]

Novo Nordisk Acquires Ocedurenone with $1.3B for Hypertension and Cardiovascular Disease

Novo Nordisk Acquires Ocedurenone with $1.3B for Hypertension and Cardiovascular Disease by Sinead Huang Novo Nordisk A/S and Singapore-based KBP Biosciences PTE., Ltd. have announced a strategic agreement, with Novo Nordisk acquiring Ocedurenone, a treatment for uncontrolled hypertension, and potential applications in cardiovascular and kidney diseases. This acquisition represents a substantial step in addressing a […]